RWM
ABBV icon

Rialto Wealth Management’s AbbVie ABBV Stock Holding History

Rialto Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
1,306
+117
+10% +$25.2K 0.07% 136
2026
Q1 		$259K Buy
1,189
+62
+6% +$13.8K 0.06% 136
2025
Q4 		$257K Sell
1,127
-12
-1% -$2.73K 0.06% 140
2025
Q3 		$264K Buy
1,139
+20
+2% +$4.07K 0.07% 134
2025
Q2 		$208K Buy
1,119
+15
+1% +$2.79K 0.06% 148
2025
Q1 		$231K Buy
1,104
+17
+2% +$3.31K 0.07% 138
2024
Q4 		$193K Buy
+1,087
New +$200K 0.06% 150

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rialto Wealth Management's ABBV Position: Q2 2026 in Review

Rialto Wealth Management increased its AbbVie (ABBV) stake by 9.8% in Q2 2026, buying an estimated $25.2K and bringing the position to 1,306 shares worth $329K. The position accounts for 0.07% of the portfolio, ranked #136.

Rialto Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Rialto Wealth Management held 1,306 shares of AbbVie worth $329K as of Q2 2026.
  • Rialto Wealth Management bought 117 AbbVie shares in Q2 2026, an estimated $25.2K.
  • AbbVie made up 0.07% of Rialto Wealth Management's portfolio in Q2 2026, its #136 holding.
  • Rialto Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.